120 related articles for article (PubMed ID: 30040917)
41. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation.
Sun Y; Cheng MK; Griffiths TR; Mellon JK; Kai B; Kriajevska M; Manson MM
Curr Cancer Drug Targets; 2013 Jan; 13(1):57-68. PubMed ID: 22920439
[TBL] [Abstract][Full Text] [Related]
42. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
Lu S; Gao Y; Huang X; Wang X
Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
[TBL] [Abstract][Full Text] [Related]
43. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
[TBL] [Abstract][Full Text] [Related]
44. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
45. 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade.
Jin H; Park MH; Kim SM
Oncol Rep; 2015 Apr; 33(4):2031-6. PubMed ID: 25633416
[TBL] [Abstract][Full Text] [Related]
46. A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF-α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT/mTOR Signal Pathway.
Du H; Zhang X; Zeng Y; Huang X; Chen H; Wang S; Wu J; Li Q; Zhu W; Li H; Liu T; Yu Q; Wu Y; Jie L
Front Immunol; 2019; 10():1620. PubMed ID: 31396207
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
Wang M; Wang W; Ding J; Wang J; Zhang J
Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
[TBL] [Abstract][Full Text] [Related]
48. The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
Wu W; Yu LH; Ma B; Xu MJ
PLoS One; 2014; 9(3):e89841. PubMed ID: 24598933
[TBL] [Abstract][Full Text] [Related]
49. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
50. The dietary phytochemical 3,3'-diindolylmethane induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-κB, MAPK, and p53 signaling.
Weng JR; Bai LY; Chiu CF; Wang YC; Tsai MH
Chem Biol Interact; 2012 Feb; 195(3):224-30. PubMed ID: 22290291
[TBL] [Abstract][Full Text] [Related]
51. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
Wang J; Xu J; Xing G
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973
[TBL] [Abstract][Full Text] [Related]
52. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
53. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
Zhang X; Qi Z; Yin H; Yang G
Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
[TBL] [Abstract][Full Text] [Related]
54. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.
Duan Z; Ames RY; Ryan M; Hornicek FJ; Mankin H; Seiden MV
Cancer Chemother Pharmacol; 2009 Mar; 63(4):681-9. PubMed ID: 18587580
[TBL] [Abstract][Full Text] [Related]
55. Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
Gritsina G; Xiao F; O'Brien SW; Gabbasov R; Maglaty MA; Xu RH; Thapa RJ; Zhou Y; Nicolas E; Litwin S; Balachandran S; Sigal LJ; Huszar D; Connolly DC
Mol Cancer Ther; 2015 Apr; 14(4):1035-47. PubMed ID: 25646015
[TBL] [Abstract][Full Text] [Related]
56. Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatment.
Zheng GF; Cai Z; Meng XK; Zhang Y; Zhu W; Pang XY; Dou L
Int J Clin Exp Pathol; 2015; 8(6):6505-11. PubMed ID: 26261528
[TBL] [Abstract][Full Text] [Related]
57. Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway.
Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986501
[TBL] [Abstract][Full Text] [Related]
58. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
[TBL] [Abstract][Full Text] [Related]
59. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]